Directors' disclosures
In accordance with the General Regulations of the Autorité des Marchés Financiers (AMF) (Article 223-22), declarations of Directors’ Shareholdings are directly available on the AMF's website (under Decisions & disclosures).
Onxeo designs and develops novel oncology drugs targeting tumor DNA repair functions.